Trilogy Metals (AMEX:TMQ) reported quarterly losses of $(0.03) per share. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year.
Reported Late Tuesday, Calliditas CEO Acquires 50,000 Shares Through The Exercise Of Calliditas’ Warrant Program 2019/2022
Calliditas Therapeutics AB (publ) (NASDAQ:CALT, Nasdaq Stockholm: CALTX)))) ("Calliditas") announced today that CEO Renée Aguiar-Lucander has net purchased 50,000 shares through Calliditas' warrant